ANSTO Chair Announcement - Reappointment of ANSTO CEO
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.
Showing 321 - 340 of 854 results
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.
Koala is one of the leading small-molecule crystallography instruments in the world for determining the complex crystal structure of a wide range of chemicals and minerals.
Researchers from Murdoch University and associated collaborators are using ANSTO’s unique nuclear capabilities to gain detailed information about how wheat crops take in administered micronutrients to maximise their efficient use.
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
In Part 2 of our series exploring the world of nuclear science and technology at ANSTO, we share more detailed information about the nuclear scientist’s toolkit.
The mining industry is set to benefit from a new Australian capability that uses a nuclear scanning technique to detect the presence of precious metals and strategic minerals in a core sample.
Hot Isostatic Pressing supports advanced manufacturing by increasing a material's density and reducing porosity. This capability complements ANSTO’s extensive suite of instruments and techniques for characterising materials and final products.
Archive of ANSTO research publications, seminars and short talks.
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
The instrument is designed to measure inelastic neutron scattering, or do neutron spectroscopy.